John Josey
InvestorPartner at The Column Group
Dallas, Texas
Writes $100K – $5M checks · typically $1.5M
Find your path to John
263 people in our graph share verified history with John — schools, employers, funds. One of them is your warm intro.
Steve TregayunlockedJohn: together at Arraybiopharma (2001–2004)
×8John: together at Amgen
×3John: together at University of Colorado
Experience
- The Column GroupPartnercurrent2026 — present
- The Column GroupVenture Partner2020 — 2026
- Peloton TherapeuticsPresident and Chief Executive Officer2013 — 2019Dallas, Texas
- Peloton TherapeuticsPresident and Chief Scientific Officer2011 — 2013Dallas, TX
- Array BioPharma Inc.Vice President, Discovery Chemistry1998 — 2011
- AmgenScientist1995 — 1998
- Glaxo Inc.Research Scientist1991 — 1995Research Triangle Park, NC
Deals · 2
Circle PharmaBoard seat
via The Column Group · filed Jan 2025 · $117.4M raise
Day One BiopharmaceuticalsBoard seat
via The Column Group · filed Feb 2021 · $130M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at The Column Group
Aadit Shah
Principal at The Column Group
Arnav Mehta, MD, PhD
Venture Partner at The Column Group
Carla Daniel
Partner at The Column Group
Craig Parker
Venture Partner at The Column Group
David Goeddel
Managing Partner at The Column Group
David V. Goeddel, Ph.D.
General Partner at The Column Group
David V. Goeddel, PhD
Partner Emeritus at The Column Group
Hui Tian
Partner at The Column Group
Frequently asked questions
- Who is John Josey?
- Partner at The Column Group
- Where does John Josey work?
- John Josey is Partner at The Column Group.
- What check size does John Josey write?
- John Josey typically writes checks of $100K – $5M.
- What boards does John Josey sit on?
- John Josey holds tracked board seats at Circle Pharma, Day One Biopharmaceuticals.
- Where did John Josey go to school?
- John Josey studied at Caltech (Postdoctoral Fellow); The University of Texas at Austin (Ph.D., Organic Chemistry); University of Colorado (MBA, Business Administration).
Same school
Also attended Caltech254
Shaun MaguirePartner at Sequoia CapitalDario AmodeiCo-founder & CEO of AnthropicFei-Fei LiCo-founder & CEO of World Labs; Sequoia Professor of Computer Science at StanfordScott BillerInvestor at GV (Google Ventures)Seth LieblichInvestment Team at 8VCSusannah BarbeeVice President, Translational Immunology at Deerfield Management Company
+ 248 more
Also attended The University of Texas at Austin751
Michael DellFounder & CEO of Dell TechnologiesViswa SankaranarayananVenture Partner at Monta Vista CapitalTodd KleinManaging Partner, Revolution Growth at RevolutionSapna MehtaInvestor at RevolutionAnish AggarwalInvestor at LightbankAndrew ScottSenior Finance Manager at Greycroft
+ 745 more
Also attended University of Colorado19
Adam AverbachChief Compliance Officer & General Counsel at Ibex InvestorsJuan Carlos SotoVenture Partner at Copper Sky CapitalJaclyn Freeman HesterGeneral Partner at FoundryJames WinterHead of Marketing at Telescope PartnersCarly AbrahamsonPartner and General Counsel at The Colorado Impact FundChris MarksManaging Partner at Firebrand Ventures
+ 13 more
Also attended Colorado State University101
Paul OsmundsonVice President Strategy & Innovation - ARUP Laboratories at EPIC VENTURESTim WeelborgGeneral Partner and co-founder of Homegrown CapitalSophia SorensenOffice Coordinator at Sorenson VenturesBraden DeforgeWealth Management Associate at Goalvest VentureAlbert J. RobichaudPartner at Cure VenturesLarry BurgessExecutives in Residence at GENERAL INCEPTION
+ 95 more
Shared employers
Also worked at The Column Group13
Tim KutzkeyManaging Partner at The Column GroupPeter SvennilsonFounder / Managing Partner at The Column GroupLeon ChenPartner at The Column GroupSarah HymowitzPartner at The Column GroupJeff GoaterPartner at The Column GroupHui TianPartner at The Column Group
+ 7 more
Also worked at Peloton Therapeutics1
Also worked at Array BioPharma Inc.6
Steve TregayManaging General Partner at Mission BiocapitalLarry BurgessExecutives in Residence at GENERAL INCEPTIONKyle LefkoffGeneral Partner at Boulder VenturesJoey MoneyLife Sciences Client Manager at Innosphere VenturesDylan HartleyExecutive Officer at Onkure Therapeutics IncKevin KochExecutive Officer, Director at Edgewise Therapeutics
Also worked at Amgen137
Parker ConradCo-founder & CEO of RipplingSeth LieblichInvestment Team at 8VCSean BruichChief Technology Officer at Flare Capital PartnersSteph ScottVice President at Questa CapitalBeth SeidenbergFounding Managing Director at Westlake Village BioPartnersKelli McKeirnanDirector of Administration at Westlake Village BioPartners
+ 131 more















































